Anti-FcRL5 CAR-T exhibit anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T:a case report
Blood Adv
.
2024 Dec 27:bloodadvances.2024014982.
doi: 10.1182/bloodadvances.2024014982.
Online ahead of print.
Authors
Xiaoyuan He
1
,
Xiaomei Zhang
2
,
Zhengyu Yu
3
,
Juanxia Meng
1
,
Yanyu Jiang
4
,
Yifan Zhao
5
,
Hairong Lyu
6
,
Xue Bai
7
,
Xia Xiao
8
,
Mingfeng Zhao
1
Affiliations
1
Tianjin First Central Hospital, Tianjin, China.
2
2Nankai University School of Medicine, China.
3
West China Hospital, Sichuan University, China.
4
Tianjin First Center Hospital, Tianjin, California, China.
5
The First Central Clinical College of Tianjin Medical University, tianjin, China.
6
Department of Hematology, Tianjin First Central Hospital, Tianjin, tianjin, China.
7
Tianjin first central hospital, Tianjin, China.
8
Tianjin First Central Hospital, Tianjin, Alabama, China.
PMID:
39729519
DOI:
10.1182/bloodadvances.2024014982
No abstract available